Non-use After Stroke: Influence of Applied Force and Precision When Reaching With the Paretic Upper Limb
NCT ID: NCT04747587
Last Updated: 2025-12-18
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
53 participants
INTERVENTIONAL
2021-05-11
2023-04-25
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
OTHER
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Patients with stroke
Reaching Session
Two x 45 minutes sessions of reaching tasks. Patients in the stroke group will perform the task with the paretic arm using a weight reduction system, allowing movement in the horizontal plane.
Subjects in the control group will perform the task with the randomly selected arm weighted at 80% of their maximum voluntary shoulder torque
Controls
Reaching Session
Two x 45 minutes sessions of reaching tasks. Patients in the stroke group will perform the task with the paretic arm using a weight reduction system, allowing movement in the horizontal plane.
Subjects in the control group will perform the task with the randomly selected arm weighted at 80% of their maximum voluntary shoulder torque
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Reaching Session
Two x 45 minutes sessions of reaching tasks. Patients in the stroke group will perform the task with the paretic arm using a weight reduction system, allowing movement in the horizontal plane.
Subjects in the control group will perform the task with the randomly selected arm weighted at 80% of their maximum voluntary shoulder torque
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patient whose stroke occurred more than a month ago.
* Patient having had a supratentorial stroke
* Patient able to touch the opposite knee with the paretic arm
* Subject who has never had a stroke
* Subject without motor or orthopedic impairment of the upper limbs and in particular of the shoulder
* Subject who has given free and informed consent.
* Subject who signed the consent form.
* Subject affiliated or beneficiary of a health insurance plan.
Exclusion Criteria
* The subject is participating in a category 1 interventional study, or is in a period of exclusion determined by a previous study
* The subject refuses to sign the consent
* It is impossible to give the subject informed information
* The patient is under safeguard of justice or state guardianship
* Patient with cognitive disorders incompatible with a good understanding of the use of the device
* Patient with other neurological or osteoarticular history that may limit the performance of the task - criterion left to the deiscretion of the investigator
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Centre Hospitalier Universitaire de Nīmes
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jérôme Froger
Role: PRINCIPAL_INVESTIGATOR
Centre Hospitalier Universitaire de Nīmes
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
CHU de Montpellier
Montpellier, , France
CHU de Nîmes
Nîmes, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
NCT04747587
Identifier Type: OTHER
Identifier Source: secondary_id
NIMAO/2020-1/JF-01
Identifier Type: -
Identifier Source: org_study_id